Terremoto Biosciences: $175 Million Raised To Develop Targeted Small Molecule Medicines

Retrieved on: 2023-11-06 22:08:15

Tags for this article:

Click the tags to see associated articles and topics

Terremoto Biosciences: $175 Million Raised To Develop Targeted Small Molecule Medicines. View article details on hiswai:

Excerpt

... Capital, Novo Holdings, Cormorant Capital, and others, as well as participation from existing investors OrbiMed and Third Rock Ventures.

Article found on: pulse2.com